M
10b5-1 Plan
$ Value
$77K
Shares
4,041
Price
$19
Filed
Feb 11
Insider
Name
Reis Mischa
Title
SVP, Strategy & Bus. Dev.
CIK
0001788632
Roles
Officer
Transaction Details
Transaction Date
2026-02-10
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
36,423
Footnotes
These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation. | The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. | This Option was fully vested as of February 24, 2023. | This Option was fully vested as of May 15, 2022.
Filing Info
Reis Mischa's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-25 | NVST | F | $88K |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-10 | NVST | M | $77K |
| 2026-02-10 | NVST | ▼ | $121K |
| 2026-02-10 | NVST | M | $90K |
| 2026-02-10 | NVST | ▼ | $169K |
| 2026-02-10 | NVST | M | $0 |
| 2026-02-10 | NVST | M | $0 |
Other Insiders at NVST (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hammes Eric D.
Chief Financial Officer
|
— | — | 2026-02-25 |
|
Keel Paul A
Chief Executive Officer
|
— | — | 2026-02-25 |
|
Nance Mark E
General Counsel
|
— | — | 2026-02-25 |
|
Reis Mischa
SVP, Strategy & Bus. Dev.
|
— | $290K | 2026-02-25 |
|
Kaabi Faez C
Chief Accounting Officer
|
— | — | 2026-02-25 |
|
Befidi Robert
President, Diagnostics
|
— | — | 2026-02-25 |
|
Nilsson Stefan
President, Nobel Biocare
|
— | — | 2026-02-25 |
|
Acurio Veronica
President, Orthodontics
|
— | — | 2026-02-25 |